Enfermedades cardio-metabólicas en el embarazo: Revisión sobre diagnóstico, tratamiento y proyección del riesgo cardiovascular a largo plazo

  • Manzur-Jattin F
  • Corrales-Santander H
  • Pacheco-Ayos C
  • et al.
N/ACitations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Cardiovascular disease is the leading cause of morbidity and mortality worldwide. Although there is a decrease in general population, the prevalence of coronary heart disease remains stable in women. Several factors typical of womenkind predispose to cardiovascular disease, including pregnancy, mediated by hematological and cardiovascular changes characteristic of it; and by associated pathologies, mainly hypertensive disorders and diabetes. The presence of these diseases has been strongly associated with future presence of other conditions of high cardiovascular risk such as chronic hypertension, dyslipidemia and diabetes mellitus. Given this impact, the identification of high-risk groups and the implementation of preventive measures, as well as early diagnosis and adequate treatment in order to reduce both maternal and fetal complications in perinatal and postpartum stages becomes imperative.

Cite

CITATION STYLE

APA

Manzur-Jattin, F., Corrales-Santander, H., Pacheco-Ayos, C., Carbonell-Riquett, L. F., González-Oñate, J., Ardila-Saenz, A., … Pérez-Llerena, L. (2020). Enfermedades cardio-metabólicas en el embarazo: Revisión sobre diagnóstico, tratamiento y proyección del riesgo cardiovascular a largo plazo. Revista Chilena de Obstetricia y Ginecología, 85(4), 408–419. https://doi.org/10.4067/s0717-75262020000400408

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free